Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(15.70) per share. This is a 95.63 percent increase over losses of $(358.94) per share from the same period last year. The company reported $1.225 million in sales this quarter. This is a 58.88 percent decrease over sales of $2.979 million the same period last year.